Catalyst Wire Dossier Catalyst Wire Dossier

AMG 340

· Amgen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMG 340, covering 2025-06-17 to 2025-06-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma [Phase 1]

See pricing